Microtubule inhibitor (halichondrin analog): Class Overview and Comparison

Quick answer: Microtubule inhibitor (halichondrin analog) are a class of medicines used for specific therapeutic indications. iMedic covers 2 microtubule inhibitor (halichondrin analog) substances. Below is a comparison table linking to detailed pages for each.

Microtubule inhibitor (halichondrin analog) on iMedic (2 substances)

Substance Primary indications Mechanism Common dose
EribulinMetastatic breast cancer, LiposarcomaNon-taxane microtubule dynamics inhibitor that arrests mitosis by sequestering t1.4 mg/m² IV on days 1 and 8 of 21-day cycle
Eribulin Advanz PharmaMetastatic breast cancer, LiposarcomaNon-taxane microtubule dynamics inhibitor that arrests mitosis by sequestering t1.4 mg/m² IV on days 1 and 8 of 21-day cycle

About Microtubule inhibitor (halichondrin analog)

Microtubule inhibitor (halichondrin analog) share a common mechanism of action and clinical use. Specific dosing, side effects, contraindications, and drug interactions vary between individual substances within the class. Click any substance above for full prescribing information and patient guidance.

Common considerations across the class

Always consult the prescribing information for the specific medicine prescribed and discuss with your clinician.

Medical disclaimer: This tool provides educational information for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your individual situation with a qualified healthcare provider.

Frequently asked questions

What are Microtubule inhibitor (halichondrin analog)?

Microtubule inhibitor (halichondrin analog) are medicines that share a common mechanism of action used for specific therapeutic indications. iMedic currently covers 2 substances in this class with detailed pages for each.

Are all Microtubule inhibitor (halichondrin analog) interchangeable?

No. While medicines in the same class share a mechanism, they differ in potency, dosing, drug interactions, and tolerability. Switching between them is a clinical decision based on individual response, side effects, and treatment goals.

How do I choose between different Microtubule inhibitor (halichondrin analog)?

Selection depends on the specific clinical indication, patient factors (age, comorbidities, kidney/liver function, other medications), tolerability of side effects, cost, and clinician preference. This is a prescribing decision.

Are Microtubule inhibitor (halichondrin analog) available as generics?

Most well-established class members are available as generic alternatives, often substantially less expensive than brand-name versions while clinically equivalent. Newer members may still be brand-only.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.